Linda Mahjoubi

Villejuif, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC).

TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC).

Journal: Cancer treatment reviews

Published: March 19, 2023

Profile and outcome of cancer patients enrolled in contemporary phase I trials.

Profile and outcome of cancer patients enrolled in contemporary phase I trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 14, 2023

Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases.

Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 12, 2020

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy.

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy.

Journal: NPJ precision oncology

Published: November 30, 2019

Corrigendum to 'A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours' [Eur J Cancer 104 (November 2018) 1-8].

Corrigendum to 'A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours' [Eur J Cancer 104 (November 2018) 1-8].

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 04, 2019

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer.

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 03, 2019

A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours.

A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 30, 2018

Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica.

Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica.

Journal: Tumori

Published: May 02, 2018

Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non-small cell lung cancer.

Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non-small cell lung cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 26, 2017

New insights into the role of EMT in tumor immune escape.

New insights into the role of EMT in tumor immune escape.

Journal: Molecular oncology

Published: March 20, 2017

Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient.

Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient.

Journal: Infection

Published: September 21, 2016

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy.

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 18, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026